Central Nervous System B-cell Non-hodgkin Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-02-28
Clinical Trial Update: Nivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating the combination of Nivolumab and Ibrutinib in relapsed or refractory central nervous system lymphom…